
Whitepaper
Accurately Estimating Blood Loss
Brian and Michael explore the challenges of estimating blood loss and discuss the key factors necessary for achieving more accurate, timely, and insightful monitoring.
White Paper
Brian and Michael explore the challenges of estimating blood loss and discuss the key factors necessary for achieving more accurate, timely, and insightful monitoring.
This whitepaper presents the findings of our systematic review conducted with Inter Scientific, evaluating the most efficacious interventions in the complex landscape of tobacco harm reduction.
Discover the exciting possibilities on the horizon for inhalation device design. Explore recent advancements and innovative strategies crucial for developing significant new treatments.
We've distilled the essence of successful diagnostic system development into this 10-minute guide - it's your compass in the intricate world of diagnostics, highlighting critical considerations essential for turning ambitious ideas into tangible solutions.
Through our latest research initiative with Foundation for a Smoke-Free World, we identified five approaches that could positively impact tobacco cessation.
This short guide gives a taste of our Smart Packaging Playbook which helps clients quickly navigate opportunities and accelerate innovation across consumer, healthcare, and industrial sectors.
This paper explores the future of drug delivery systems, specifically at-home self-injection, and the way in which drugs will be packaged in the future to enhance patient experience and ensure successful clinical outcomes.
Our Roadmap defines the key technologies and strategies that can place the UK at the forefront of the IVD industry.
Using a range of case studies, this white paper highlights some of the key considerations around regulation for FemTech innovators.
The ENDS Adoption Journey outlines seven steps a smoker must take to substitute combustible tobacco products with ENDS.
The future of diagnostics and digital health monitoring will be centred firmly around the patient.
It can be extremely challenging to identify an optimum business and product strategy in the current cannabinoid market.